The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Thromboembolic events in immunomodulatory drug (IMiD)–sparing regimens for patients with newly diagnosed multiple myeloma (NDMM).
 
Gliceida Galarza Fortuna
No Relationships to Disclose
 
John McCarron
No Relationships to Disclose
 
Elena Nazarenko
No Relationships to Disclose
 
Yizhe Xu
No Relationships to Disclose
 
Kian Rahbari
No Relationships to Disclose
 
Ming Lim
Consulting or Advisory Role - Bayer; Biomarin; HEMA Biologics; Sanofi
 
Kristen Sanfilippo
Other Relationship - American Society of Hemotology; National Heart, Lung, and Blood Institute; Quinn Johnston
 
Brian McClune
No Relationships to Disclose
 
Ghulam Rehman Mohyuddin
Honoraria - MashupMD; Medscape
Research Funding - Janssen (Inst)
 
Amandeep Godara
Consulting or Advisory Role - Janssen; Sanofi
Other Relationship - Genzyme
 
Douglas Sborov
Consulting or Advisory Role - Abbvie; Arcellx; AstraZeneca; BiolineRx; Bristol-Myers Squibb/Celgene; Genentech; GlaxoSmithKline; Janssen; Opna Bio; Pfizer; Sanofi
Research Funding - Pfizer
 
Muhamed Baljevic
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Genzyme; Janssen Biotech; Parexel International; Pfizer; Prothena
Expert Testimony - Faraci Lange, LLP